Department of Pathophysiology and Transplantation, University of Milan, Milano, Italy ; Medicina Interna, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Unità Operativa di Allergologia e Immunologia Clinica, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Exp Hematol Oncol. 2014 Jun 4;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014.
A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell units were transfused over three days). High circulating levels of anti-VW factor immunoglobulin M were documented immunoenzimatically. Heart ultrasound showed abnormalities of the mitral and aortic valves with severe flow alterations. When intravenous immunoglobulins were added to therapy, prompt clinical and laboratory responses occurred: complete cessation of bleeding, raise in hemoglobin, VW factor antigen, VW ristocetin cofactor and factor VIII levels as well as progressive reduction of the anti-VWF autoantibody levels.
一位 91 岁女性患有获得性血管性血友病(VW)综合征和肠血管扩张症,出现严重胃肠道出血(血红蛋白 5 g/dl)。尽管使用 VW 因子/因子 VIII 浓缩物 qid 进行替代治疗,但出血仍未停止(在三天内输注了 11 个单位的浓缩红细胞)。免疫酶法检测到循环中高水平的抗 VW 因子免疫球蛋白 M。心脏超声显示二尖瓣和主动脉瓣异常,伴有严重的血流改变。当静脉注射免疫球蛋白加入治疗时,迅速出现临床和实验室反应:出血完全停止,血红蛋白、VW 因子抗原、VW 瑞斯托菌素辅因子和因子 VIII 水平升高,以及抗 VW 因子自身抗体水平逐渐降低。